International Clinical Trial: A Multicenter Exploratory Clinical Study of Targeted NK Cell Inhibition for Transplant Kidney Chronic Active Antibody-Mediated Rejection (caABMR): Single Induction with CD38 Monoclonal Antibody Followed by Sequential Maintenance with Azathioprine

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132756) titled 'A Multicenter Exploratory Clinical Study of Targeted NK Cell Inhibition for Transplant Kidney Chronic Active Antibody-Mediated Rejection (caABMR): Single Induction with CD38 Monoclonal Antibody Followed by Sequential Maintenance with Azathioprine' on Sept. 18.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The First Affiliated Hospital of Zhejiang University School of Medicine

Condition: Chronic active antibody-mediated rejection

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-18

Target Sample Size: Experimental group:20;

Countries of Recr...